RENOVORX, INC.
Last · —$1.12-0.03 (-2.61%)live · yahoo · 6m ago
Market cap$50.55M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | $1.1M |
|---|---|
| Operating income | $-12.5M |
| Net income | $-11.2M |
| Free cash flow | $-11.0M |
| Operating margin | -1114.0% |
| Net margin | -994.5% |
| Return on equity | -206.0% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-30
- Sbc Revenue High
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Cash Runway Low
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Sbc Revenue High — SBC/Revenue 112.8%
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -994.5%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -977.1%
- Cash Runway Low — Cash runway ~0.6 years
- Accumulated Deficit High — Accumulated deficit / equity 1132%
- Rd Intensity High — R&D/Revenue 558.2%
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.05
Est. revenue
1.1M
Earnings transcripts
Press & signals
- GlobeNewswire
RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth